Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BreathID Hp Systems in Pediatric H. pylori
NCT02905825Phase 3Completed
- Sponsor
- Meridian Bioscience
- Start
- May 2017
- Primary completion
- Oct 2017
- Countries
- 2
01
Overview
Phase 3, open-label, single-arm trial, sponsored by Meridian Bioscience. Primary endpoint: Number of Participants With Reported Adverse Events at 24 hours. Started May 2017; status: completed.
Beyond the preview
Go deeper on NCT02905825.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02905825.